English version

Final Programme

Download the final Programme

 

Monday, 29th March 2010

8:30
9:15

 

Welcome at Zoe

   

9:15
9:30

 

Opening Session
Dr. R. Le Grand (CEA, France) and X. Morge (SPI-Bio, France)

     

9:30
10:30

 

Session I: Clinical trials: Regulatory aspects

     

10:00
10:30

 

Regulatory requirements for clinical trials
(Dr. F. Verdier, Sanofi-Pasteur, France)

     

10:30
11:00

 

Coffee Break at Zoe

     

11:00
12:30

 

Session II: Deciphering the immune response

     

11:00
11:30

 

Assessing T-Cell memory in antiviral vaccines
(Dr. RP. Sekaly, Vaccine and gene therapy Institute, Canada)

     

11:30
12:00

 

High throughput management of data from flow cytometry
(Dr. A. Cosma, CEA, France)

     

12:00
14:00

 

Lunch at Zoe

     

14:00
15:00

 

Session III: Advanced technologies in immunomonitoring

     

14:00
14:30

 

Tools and perspectives for standardization and immunomonitoring in flow cytometry
(Dr. C. Maier, BD Biosciences, France)

     

14:30
15:00

 

New tools for multiparametric analysis
(Dr. C. Vallan, FlowJo, France)

     

15:00
17:00

 

Session IV: Early biomarkers identification and predictivity in clinical trials (Part I)

     

15:00
15:30

 

Immunomonitoring in clinical trials CANCELLED
(Pr. Y. Levy, INSERM, Paris)

     

15:30
16:00

 

Coffee Break at Zoe

     

16:30
17:00

 

Measuring the status of the immune system through blood genomics
(Dr. D. Chaussabel, Baylor Institute for Immunological Research, USA)

     

17:00
17:30

 

Conclusion followed by social Event at Pre Catelan

------------------------------------------------------

Tuesday 30th March 2010

8:30
9:00

 

Welcome at Zoe

   

9h00
10h00

 

Session IV: Early biomarkers identification and predictivity in clinical trials (Part II)

     

9:00
9:30

 

Immunomonitoring of patients treated with TNF-α antagonists
(Pr. D. Emilie, INSERM, France)

     

9:30
10:00

 

Mucosal Immunology Issues on Human Vaginal Sampling
(Dr. V. Jespers, Institute of Tropical Medicine, Belgium)

     

10:00
10:30

 

Coffee Break at Zoe

     

10:30
12:00

 

Session V: Translational immunological approaches

     

10:30
11:00

 

Gene expression biomarkers of tolerance and rejection in transplantation
(Dr. Joanna Ashton-Chess , TcLand expression, CIMNA, France)

     

11:00
11:30

 

Interest of pre-clinic assays in immunological biosafety
(Dr. A.-C. Rimaniol, SPI-Bio, France)

     

11:30
12:00

 

New paradigm in the capture and management of clinical and genomic data
(Dr. Jonathan Sheldon, IDBS)

     

12:00
12h15

 

Closing Session
Dr. R. Le Grand (CEA, France) and X. Morge (SPI-Bio, France)

     

12:15
13:30

 

Closing Cocktail at Zoe